How fullerene derivatives (FDs) act on therapeutically important targets associated with diabetic diseases.
Ontology highlight
ABSTRACT: Fullerene derivatives (FDs) belong to a relatively new family of nano-sized organic compounds. They are widely applied in materials science, pharmaceutical industry, and (bio) medicine. This research focused on the study of FDs in terms of their potential inhibitory effect on therapeutic targets associated with diabetic disease, as well as analysis of protein-ligand binding in order to identify the key binding characteristics of FDs. Therapeutic drug compounds when entering the biological system usually inevitably encounter and interact with a vast variety of biomolecules that are responsible for many different functions in organisms. Protein biomolecules are the most important functional components and used in this study as target structures. The structures of proteins [(PDB ID: 1BMQ, 1FM
SUBMITTER: Fjodorova N
PROVIDER: S-EPMC8861571 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA